We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $171B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
-4.79%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$64.6B
AUM Growth
+$2.32B
Cap. Flow
+$5.54B
Cap. Flow %
8.59%
Top 10 Hldgs %
48.18%
Holding
2,491
New
420
Increased
1,148
Reduced
611
Closed
122

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.68%
2 Technology 4.76%
3 Financials 3.35%
4 Consumer Discretionary 1.79%
5 Healthcare 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITC icon
1501
SITE Centers
SITC
$151M
$371K ﹤0.01%
28,463
RGEN icon
1502
Repligen
RGEN
$9.51B
$369K ﹤0.01%
1,962
-19
-1% -$3.61K
IDA icon
1503
Idacorp
IDA
$7.98B
$368K ﹤0.01%
3,186
+871
+38% +$94.8K
CEQP
1504
DELISTED
Crestwood Equity Partners LP
CEQP
$368K ﹤0.01%
12,316
BAFN icon
1505
BayFirst Financial Corp
BAFN
$204M
$365K ﹤0.01%
+15,837
New +$353K
WH icon
1506
Wyndham Hotels & Resorts
WH
$5.19B
$365K ﹤0.01%
4,305
+36
+0.8% +$3.06K
KNX icon
1507
Knight Transportation
KNX
$11.5B
$364K ﹤0.01%
7,209
+91
+1% +$5.02K
REZI icon
1508
Resideo Technologies
REZI
$2.98B
$364K ﹤0.01%
15,283
+130
+0.9% +$3.26K
IMCV icon
1509
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.17B
$363K ﹤0.01%
5,274
FIW icon
1510
First Trust Water ETF
FIW
$1.8B
$362K ﹤0.01%
4,298
+179
+4% +$14.9K
CE icon
1511
Celanese
CE
$4.89B
$361K ﹤0.01%
2,524
-1,227
-33% -$187K
WST icon
1512
West Pharmaceutical
WST
$23.8B
$360K ﹤0.01%
877
+152
+21% +$59.5K
INSP icon
1513
Inspire Medical Systems
INSP
$1.8B
$358K ﹤0.01%
1,394
-93
-6% -$21.3K
NKLA
1514
DELISTED
Nikola Corporation Common Stock
NKLA
$357K ﹤0.01%
1,110
-180
-14% -$45.9K
FBT icon
1515
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
$356K ﹤0.01%
+2,384
New +$353K
INDS icon
1516
Pacer Industrial Real Estate ETF
INDS
$110M
$356K ﹤0.01%
7,000
+105
+2% +$5.21K
TKR icon
1517
Timken Company
TKR
$8.58B
$355K ﹤0.01%
5,854
+144
+3% +$9.57K
ADRE
1518
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$355K ﹤0.01%
+8,074
New +$366K
ESLT icon
1519
Elbit Systems
ESLT
$33.2B
$354K ﹤0.01%
1,604
+396
+33% +$74.8K
FNCL icon
1520
Fidelity MSCI Financials Index ETF
FNCL
$2.4B
$354K ﹤0.01%
6,545
+2,124
+48% +$118K
NDSN icon
1521
Nordson
NDSN
$17.6B
$354K ﹤0.01%
1,561
+178
+13% +$40.9K
PEY icon
1522
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.14B
$354K ﹤0.01%
16,218
+900
+6% +$19.3K
STAG icon
1523
STAG Industrial
STAG
$7.24B
$354K ﹤0.01%
8,568
+3,429
+67% +$142K
DFE icon
1524
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
$353K ﹤0.01%
5,250
-274
-5% -$18.9K
JEF icon
1525
Jefferies Financial Group
JEF
$12.8B
$353K ﹤0.01%
11,232
-960
-8% -$32.6K

Similar funds

Creative Planning's Q1 2022 Portfolio in Review

As of Q1 2022, Creative Planning held 2,491 positions worth $64.6B, up 3.7% from $62.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Creative Planning deployed $5.54B of net new capital in Q1 2022, opening 420 new positions and adding to 1,148 existing holdings. Its largest new stake was CVB Financial: 1,171,947 shares worth $27.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 85% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $325M trimmed.

  • Creative Planning's largest Q1 2022 buy was CVB Financial: 1,171,947 shares worth $27.2M.
  • Creative Planning added most to Vanguard Morningstar Total Stock Market ETF in Q1 2022, an estimated $1.14B increase.
  • Creative Planning's biggest Q1 2022 reduction was Vanguard Total Bond Market, cutting an estimated $325M.
  • Creative Planning fully exited LCNB Corp in Q1 2022, selling an estimated $12.4M.
  • Creative Planning's ten largest holdings make up 48% of its $64.6B portfolio in Q1 2022.
  • Creative Planning opened 420 new positions and closed 122 in Q1 2022.
  • Creative Planning's portfolio value rose 3.7% quarter-over-quarter to $64.6B.

Based on Creative Planning's 13F filing for Q1 2022, filed 16 May 2022.